Sharon Diamond

2.3k total citations
21 papers, 1.0k citations indexed

About

Sharon Diamond is a scholar working on Infectious Diseases, Oncology and Virology. According to data from OpenAlex, Sharon Diamond has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Oncology and 6 papers in Virology. Recurrent topics in Sharon Diamond's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Sharon Diamond is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Sharon Diamond collaborates with scholars based in United States, New Zealand and Germany. Sharon Diamond's co-authors include Swamy Yeleswaram, Jason Boer, James D. Rodgers, Lee T. Bacheler, Susan Erickson‐Viitanen, George L. Trainor, Yu Li, Soo S. Ko, Susan Jeffrey and Ronald M. Klabe and has published in prestigious journals such as Blood, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Sharon Diamond

20 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Diamond United States	12	348	307	184	168	131	21	1.0k
Zaina T. Al-Salama New Zealand	17	322 0.9×	91 0.3×	262 1.4×	100 0.6×	44 0.3×	35	1.0k
Prabhu Rajagopalan United States	17	365 1.0×	98 0.3×	360 2.0×	72 0.4×	71 0.5×	51	1.1k
Julian S. Kroin United States	10	531 1.5×	282 0.9×	549 3.0×	150 0.9×	65 0.5×	13	1.2k
Richard M. Keenan United States	23	576 1.7×	394 1.3×	175 1.0×	46 0.3×	52 0.4×	39	1.4k
Ruo W. Steensma United States	8	313 0.9×	148 0.5×	254 1.4×	118 0.7×	38 0.3×	9	740
Hon‐Wah Man United States	17	784 2.3×	412 1.3×	277 1.5×	50 0.3×	91 0.7×	24	1.5k
Xinglin Wu United States	10	406 1.2×	52 0.2×	259 1.4×	155 0.9×	38 0.3×	25	957
Peter D. Gorycki United States	13	344 1.0×	146 0.5×	166 0.9×	25 0.1×	29 0.2×	29	735
Delores Mowles Canada	15	517 1.5×	54 0.2×	636 3.5×	239 1.4×	132 1.0×	22	1.4k
Melinda J. Reese United States	16	156 0.4×	22 0.1×	128 0.7×	250 1.5×	191 1.5×	18	1.1k

Countries citing papers authored by Sharon Diamond

Since Specialization

Citations

This map shows the geographic impact of Sharon Diamond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Diamond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Diamond more than expected).

Fields of papers citing papers by Sharon Diamond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Diamond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Diamond. The network helps show where Sharon Diamond may publish in the future.

Co-authorship network of co-authors of Sharon Diamond

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Diamond. A scholar is included among the top collaborators of Sharon Diamond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Diamond. Sharon Diamond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Anlai, Ke Zhang, Joshua R. Hummel, et al.. (2022). Discovery of Pyrazolopyridine Derivatives as HPK1 Inhibitors. ACS Medicinal Chemistry Letters. 14(1). 5–10. 8 indexed citations

Burns, David, Chunhong He, Yunlong Li, et al.. (2022). Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1. Bioorganic & Medicinal Chemistry Letters. 73. 128884–128884. 1 indexed citations

Drake, Katherine, Yvonne Lo, Min Ye, et al.. (2022). Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors. ACS Medicinal Chemistry Letters. 13(11). 1797–1804. 7 indexed citations

Persaud, Indushekhar, et al.. (2020). Plasma pharmacokinetics and distribution of ruxolitinib into skin following oral and topical administration in minipigs. International Journal of Pharmaceutics. 590. 119889–119889. 15 indexed citations

Chen, Yaoyu, Matthew C. Stubbs, Xiaoming Wen, et al.. (2020). Characterization of INCB00928, a Potent and Selective ALK2 Inhibitor for the Treatment of Anemia. Blood. 136(Supplement 1). 52–52. 9 indexed citations

Zhang, Yan, Kevin Bowman, Janet Maleski, Sharon Diamond, & Swamy Yeleswaram. (2019). Short Communication: Effects of Epacadostat on Brain Extracellular Fluid Concentrations of Serotonin—an Intracerebral Microdialysis Study in Sprague-Dawley Rats. Drug Metabolism and Disposition. 47(7). 710–714.

Zhang, Qiang, Yan Zhang, Jason Boer, et al.. (2017). In Vitro Interactions of Epacadostat and its Major Metabolites with Human Efflux and Uptake Transporters: Implications for Pharmacokinetics and Drug Interactions. Drug Metabolism and Disposition. 45(6). 612–623. 12 indexed citations

Zhang, Yan, Mark S. Warren, Xuexiang Zhang, et al.. (2015). Impact on Creatinine Renal Clearance by the Interplay of Multiple Renal Transporters: A Case Study with INCB039110. Drug Metabolism and Disposition. 43(4). 485–489. 33 indexed citations

Zhang, Qiang, Yan Zhang, Sharon Diamond, et al.. (2014). The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy. Drug Metabolism and Disposition. 42(10). 1656–1662. 85 indexed citations

10.

Liu, Xiangdong, Qian Wang, Gengjie Yang, et al.. (2011). A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3. Clinical Cancer Research. 17(22). 7127–7138. 190 indexed citations

11.

Diamond, Sharon, Jason Boer, Thomas Maduskuie, et al.. (2010). Species-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological Implications. Drug Metabolism and Disposition. 38(8). 1277–1285. 106 indexed citations

12.

Shilling, Adam D., Frank M. Nedza, Thomas Emm, et al.. (2010). Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans. Drug Metabolism and Disposition. 38(11). 2023–2031. 86 indexed citations

13.

Daniels, J. Scott, Robert Espina, Lin Jian-rong, et al.. (2007). Species-Specific, P450- and Sulfotransferase-Mediated Novel Ring Contraction of a Naphthyridine-N-Oxide Compound in Cynomolgus Monkey. Chemical Research in Toxicology. 20(11). 1709–1717. 5 indexed citations

14.

Wong, Harvey, Scott Grossman, Stephen A. Bai, et al.. (2004). THE CHIMPANZEE (PAN TROGLODYTES) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION. Drug Metabolism and Disposition. 32(12). 1359–1369. 21 indexed citations

15.

Solon, Eric, Suresh K. Balani, Gang Luo, et al.. (2002). Interaction of Ritonavir on Tissue Distribution of a [14C]L-Valinamide, a Potent Human Immunodeficiency Virus-1 Protease Inhibitor, in Rats Using Quantitative Whole-Body Autoradiography. Drug Metabolism and Disposition. 30(11). 1164–1169. 10 indexed citations

16.

Schinazi, Raymond F., John W. Mellors, Holly Bazmi, et al.. (2002). DPC 817: a Cytidine Nucleoside Analog with Activity against Zidovudine- and Lamivudine-Resistant Viral Variants. Antimicrobial Agents and Chemotherapy. 46(5). 1394–1401. 39 indexed citations

17.

Cocuzza, Anthony J., Dennis R. Chidester, Beverly C. Cordova, et al.. (2001). 4,1-Benzoxazepinone analogues of efavirenz (Sustiva™) as HIV-1 reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry Letters. 11(11). 1389–1392. 18 indexed citations

18.

Kaltenbach, Robert F., George L. Trainor, Daniel P. Getman, et al.. (2001). DPC 681 and DPC 684: Potent, Selective Inhibitors of Human Immunodeficiency Virus Protease Active against Clinically Relevant Mutant Variants. Antimicrobial Agents and Chemotherapy. 45(11). 3021–3028. 8 indexed citations

19.

Corbett, Jeffrey W., Soo S. Ko, James D. Rodgers, et al.. (2000). Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. 43(10). 2019–2030. 272 indexed citations

20.

Corbett, Jeffrey W., Soo S. Ko, James D. Rodgers, et al.. (1999). Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 43(12). 2893–2897. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact